Altria Group (MO)
(Delayed Data from NYSE)
$50.10 USD
+0.12 (0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $50.02 -0.08 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$50.10 USD
+0.12 (0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $50.02 -0.08 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Zacks News
Factors to Know Ahead of Altria's (MO) Q4 Earnings Release
by Zacks Equity Research
Altria's (MO) fourth-quarter 2020 results are likely to reflect gains from pricing as well as strength in the Oral Tobacco Products segment, though cigarette volumes have been soft for a while.
McCormick (MKC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
McCormick's (MKC) fourth-quarter fiscal 2020 performance is likely to reflect strength in the Consumer Business unit due to high demand amid COVID-19, while the Flavors Solution unit has been soft.
Here's How Mondelez (MDLZ) is Placed Ahead of Q4 Earnings
by Zacks Equity Research
Higher demand in developed markets amid COVID-19 is likely to get reflected in Mondelez's (MDLZ) fourth-quarter 2020 performance. However, sluggish performance in some emerging markets is a concern.
Altria (MO) Stock Moves -0.26%: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $41.83 in the latest trading session, marking a -0.26% move from the prior day.
Will Altria (MO) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Altria (MO) Gains on Low Risk Tobacco Products & Strong Pricing
by Zacks Equity Research
Altria's (MO) efforts to boost oral tobacco offerings and expansion of IQOS across stores are yielding. Moreover, pricing power is aiding revenue growth.
The Zacks Analyst Blog Highlights: Apple, Mastercard, Sanofi, Comcast and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Mastercard, Sanofi, Comcast and Altria Group
Top Stock Reports for Apple, Mastercard & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA), and Sanofi (SNY).
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $41.11 in the latest trading session, marking a +0.05% move from the prior day.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $41.59 in the latest trading session, marking a -0.45% move from the prior day.
Will RRPs Growth Keep Driving Philip Morris (PM) in 2021?
by Zacks Equity Research
Philip Morris (PM) is gaining from growing popularity of IQOS, which is boosting revenues in the RRPs category.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.87, marking a +0.75% move from the previous day.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43, moving -0.23% from the previous trading session.
Altria (MO) Gains on Low-Risk Products Amid Soft Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from the popularity of low-risk tobacco alternatives such as IQOS and on!, as well as prudent pricing strategies.
RRPs Gaining Popularity: 3 Tobacco Stocks to Watch in 2021
by Vidya Nair
Tobacco industry players like PM, MO, and TPB are poised to benefit from rising popularity of low-risk tobacco alternatives. However, low cigarette sales volumes are likely to remain a headwind.
Top Research Reports for Facebook, Verizon & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Verizon Communications (VZ) and Sanofi (SNY).
Philip Morris's (PM) IQOS 3 Receives FDA Authorization for Sale
by Zacks Equity Research
FDA approves the sale of Philip Morris's (PM) IQOS devices in the United States. The latest device includes a number of technological advancements compared with its predecessors.
Why Is Altria (MO) Up 9.5% Since Last Earnings Report?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, HSBC Holdings, Exxon Mobil and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, HSBC Holdings, Exxon Mobil and Altria Group
Top Analyst Reports for Walmart, AstraZeneca & HSBC
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), AstraZeneca (AZN) and HSBC Holdings (HSBC).
Altria's (MO) Q3 Earnings Surpass Estimates on Solid Pricing
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results reflect strong pricing in smokeable and oral tobacco product segments. Management lifts the lower end of its previously guided earnings view.
Altria (MO) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 3.48% and 2.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Altria (MO) Might Surprise This Earnings Season
by Zacks Equity Research
Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Altria (MO) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results are likely to reflect gains from pricing and strength in oral tobacco products. However, cigarette volumes have been soft for a while.
Altria (MO) Stock Moves -1.31%: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $38.57 in the latest trading session, marking a -1.31% move from the prior day.